SCHEMBL16626628

SCHEMBL16626628

CNCc1cn(S(=O)(=O)c2cccnc2)c2cc(Cc3ccc(OC(F)(F)F)cc3F)ccc12

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 5/20 0.38
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
NAMPT P43490 3/20 0.36
MAT2A P31153 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PPARG P37231 1/20 0.35
PPARD Q03181 1/20 0.35
PPARA Q07869 1/20 0.35
CNR2 P34972 2/20 0.35
P2RX7 Q99572 1/20 0.35
IDE P14735 1/20 0.35
SLC40A1 Q9NP59 1/20 0.35
GRM2 Q14416 1/20 0.35
CHRM5 P08912 1/20 0.34
ROCK2 O75116 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16619705 0.99 HTR6 (0.37) HTR6CYP11B1CYP11B2NAMPTMAT2A
SCHEMBL17975821 0.92 HTR6 (0.38) HTR6CYP11B1CYP11B2NAMPTMAT2A
SCHEMBL16626647 0.91 NAMPT (0.39) HTR6CYP11B1CYP11B2NAMPTMAT2A
Hydrochloric Acid SCHEMBL16618980 0.91 HTR6 (0.37) HTR6CYP11B1CYP11B2NAMPTMAT2A
SCHEMBL16626785 0.91 HTR6 (0.44) HTR6CYP11B1CYP11B2NAMPT
SCHEMBL16626784 0.91 HTR6 (0.42) HTR6CYP11B1CYP11B2NAMPTMAT2A
SCHEMBL16626649 0.91 HTR6 (0.38) HTR6CYP11B1CYP11B2NAMPTMAT2A
Hydrochloric Acid SCHEMBL16618888 0.91 NAMPT (0.38) HTR6CYP11B1CYP11B2NAMPTMAT2A
Hydrochloric Acid SCHEMBL16618742 0.90 HTR6 (0.43) HTR6CYP11B1CYP11B2NAMPT
Hydrochloric Acid SCHEMBL16618786 0.90 HTR6 (0.42) HTR6CYP11B1CYP11B2NAMPTMAT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP claimed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
WO-2015050412-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME GIPR, PGC, SI HTR6 166/4885CYP11B1 4108/4885CYP11B2 3729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.